From: 11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study
Estimated risk
Addition of RT boost to pelvic LN
Change to no/palliative RT
≤45% (n =11)
4
7
>45% (n =9)
5